Hussein A N Al-Wadei1, Hildegard M Schuller2. 1. Experimental Oncology Laboratory, Department of Pathobiology, College of Veterinary Medicine, University of Tennessee, 2407 River Drive, Knoxville, TN 37996, USA; Sana'a University, Sana'a, Yemen. 2. Experimental Oncology Laboratory, Department of Pathobiology, College of Veterinary Medicine, University of Tennessee, 2407 River Drive, Knoxville, TN 37996, USA. Electronic address: hmsch@utk.edu.
Abstract
AIM: beta-Carotene has shown cancer-preventive effects in preclinical studies while increasing lung cancer mortality in clinical trials. We have shown that beta-carotene stimulates cAMP signalling in vitro. Here, we have tested the hypothesis that beta-carotene promotes the development of pulmonary adenocarcinoma (PAC) in vivo via cAMP signalling. METHODS: PAC was induced in hamsters with the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), followed by beta-carotene for 1.5 years. Incidence, multiplicity and size of lung tumours were recorded, and phosphorylated CREB and ERK1/2 in tumour cells were determined by Western blots. Cyclic AMP in blood cells was analysed by immunoassays, retinoids in serum and lungs by HPLC. RESULTS: beta-Carotene increased lung tumour multiplicity, lung tumour size, blood cell cAMP, serum and lung levels of retinoids and induced p-CREB and p-ERK1/2 in lung tumours. CONCLUSIONS: Our data suggest that beta-carotene promotes the development of PAC via increased cAMP signalling.
AIM: beta-Carotene has shown cancer-preventive effects in preclinical studies while increasing lung cancer mortality in clinical trials. We have shown that beta-carotene stimulates cAMP signalling in vitro. Here, we have tested the hypothesis that beta-carotene promotes the development of pulmonary adenocarcinoma (PAC) in vivo via cAMP signalling. METHODS: PAC was induced in hamsters with the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), followed by beta-carotene for 1.5 years. Incidence, multiplicity and size of lung tumours were recorded, and phosphorylated CREB and ERK1/2 in tumour cells were determined by Western blots. Cyclic AMP in blood cells was analysed by immunoassays, retinoids in serum and lungs by HPLC. RESULTS:beta-Carotene increased lung tumour multiplicity, lung tumour size, blood cell cAMP, serum and lung levels of retinoids and induced p-CREB and p-ERK1/2 in lung tumours. CONCLUSIONS: Our data suggest that beta-carotene promotes the development of PAC via increased cAMP signalling.
Authors: S Maudsley; K L Pierce; A M Zamah; W E Miller; S Ahn; Y Daaka; R J Lefkowitz; L M Luttrell Journal: J Biol Chem Date: 2000-03-31 Impact factor: 5.157
Authors: M E Garber; O G Troyanskaya; K Schluens; S Petersen; Z Thaesler; M Pacyna-Gengelbach; M van de Rijn; G D Rosen; C M Perou; R I Whyte; R B Altman; P O Brown; D Botstein; I Petersen Journal: Proc Natl Acad Sci U S A Date: 2001-11-13 Impact factor: 11.205
Authors: M Alexandre; A K Uduman; S Minervini; A Raoof; C A Shugrue; E O Akinbiyi; V Patel; M Shitia; T R Kolodecik; R Patton; F S Gorelick; E C Thrower Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-07-26 Impact factor: 4.052